| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 6,123,963 | 5,912,566 | 4,860,465 | | Cost of Revenue | 5,435,257 | 4,334,352 | 4,365,005 | | | Gross Profit | 688,705 | 1,578,215 | 495,460 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,763,278 | 788,109 | 817,340 | | Non Recurring | 436,679 | 125,108 |
-
| | Others | 701,455 | 659,714 | 96,578 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,212,706) | 5,283 | (418,458) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 302,440 | 353,511 | (100,988) | | Earnings Before Interest And Taxes | (1,896,517) | 370,914 | (502,375) | | Interest Expense | 341,539 | 334,135 |
-
| | Income Before Tax | (2,238,057) | 36,779 | (502,375) | | Income Tax Expense | 10,843 | 3,258 | (17,827) | | Minority Interest |
-
|
-
| 15,211 | | | | Net Income From Continuing Ops | (2,248,900) | 33,521 | (469,336) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,248,900) | 33,521 | (469,336) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,248,900) | $33,521 | ($469,336) |
|
0.83% Nasdaq 0.00%
Income Statement
